HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the […]
SAN DIEGO — Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) announced today that it has terminated the merger agreement with Tarveda Therapeutics, Inc. (“Tarveda”), originally announced on December 16, 2019, and will continue to operate as an independent company. The Company had submitted the merger proposal and other related proposals to be voted upon at a Special Meeting of Stockholders, as described […]
— Unanticipated late opposition by major Organovo stockholder results in termination of proposed merger agreement — — Tarveda continues advancement of current Pentarin® miniature drug conjugate clinical programs towards key clinical milestones — Watertown, MA – Tarveda Therapeutics, Inc. (“Tarveda”), a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it […]
Latest Acquisition Enhances Wiley Science Solutions Furthering Laboratory Impact HOBOKEN, N.J.–John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB), a global leader in research and education, today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases. The acquisition adds expertise, content, and powerful software to Wiley’s Science Solutions segment. Terms of […]
BOSTON, Mass.—GE (NYSE:GE) announced today the completion of the sale of its BioPharma business to Danaher Corporation (NYSE:DHR) (“Danaher”) for approximately $20 billion of net proceeds. GE Chairman and CEO H. Lawrence Culp, Jr., said, “Completing the sale of BioPharma represents a critical milestone on our multi-year transformation, fortifying our considerable sources to de-risk our […]
To view this release online and get more information about Danaher Corporation: IR Room visit: https://investors.danaher.com/2020-03-31-Danaher-Completes-Acquisition-Of-The-Biopharma-Business-Of-General-Electric-Life-Sciences-Business-Will-Be-Called-Cytiva WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today the completion of its acquisition of the Biopharma business from General Electric Company’s (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a […]
Irvine, CA – BioDot Inc. (BioDot or the Company), a leading manufacturer of automated ultralow volume fluid dispensing systems, announced today that it has been acquired by Artemis Capital Partners (Artemis), a Boston-based private equity firm focused exclusively on partnering with differentiated industrial technology companies. Since its founding in 1994, BioDot has become an undisputed leader […]
BOSTON, Mass. — GE (NYSE:GE) announced that, together with Danaher Corporation (NYSE:DHR) (“Danaher”), it has entered into a consent decree agreement with the U.S. Federal Trade Commission (the “FTC”) in connection with GE’s definitive agreement to sell its BioPharma business to Danaher for approximately $20 billion of net proceeds. GE currently expects to close the […]
On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction originally announced in October 2019, the completion of which is still subject to clearance by the Chinese antitrust enforcement […]
SAN DIEGO – Maravai LifeSciences, a global provider of life science reagents and services to researchers and biotech partners, announced today that it has acquired MockV Solutions. MockV plays an important role in helping biopharma customers develop manufacturing processes that are free of viral contamination, leading to the production of safe biotherapeutics. The MockV acquisition, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
